# 2026-22381: Federal Rule Reworks How Organ Procurement Groups Are Held Accountable

2026-22381, Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage, is a Federal Register rule from Health and Human Services Department, Centers for Medicare & Medicaid Services published 2026-11-03, effective 2027-01-04; deemed significant under Executive Order 12866; PRIA reads it as touching household money (as of 2026-11-10).

- Canonical: https://policyrisk.com/federal-register/2026-22381
- As of: 2026-11-10
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-22381
- Title: Medicare and Medicaid Programs; Organ Procurement Organizations Conditions for Coverage: Revisions to the Conditions for Coverage
- Type: Rule
- Agencies: Health and Human Services Department; Centers for Medicare & Medicaid Services
- Citation: 91 FR 69390
- Published: 2026-11-03
- Effective: 2027-01-04
- Comments close: not stated
- Significant: yes (FR_METADATA)
- Touches household money: yes
- Regulation identifier numbers: 0938-AU54
- Last updated: 2026-11-10

## In one line

Federal Rule Reworks How Organ Procurement Groups Are Held Accountable

## Summary

This new rule updates how Organ Procurement Organizations (OPOs) operate to help get more life-saving organs to people who need transplants. It changes some definitions, competition rules, and appeal processes to make OPOs work better and be held accountable. These changes start January 4, 2027, and aim to save more lives without adding extra costs.

## Abstract

This final rule revises the Conditions for Coverage for Organ Procurement Organizations (OPOs) to clarify outstanding procedural questions and provide additional operational flexibility for OPOs to achieve high performance resulting in the successful procurement, distribution, and transplantation of more life-saving organs. This rule revises definitions, revises the designation requirements for OPOs, clarifies when an OPO's service area is open for competition, and updates the process for appeals. We are committed to holding all OPOs accountable for their performance and this final rule does not revise the focus on improving the volume of donors and transplants assessed in the outcome measures or the tier structure used for re-certification and de-certification of OPOs.

## Effects PRIA read

- Pancreata Excluded from Transplant Rate: benefit, low. CMS revised the definition of “organ” so that pancreata used for islet cell research and not transplanted are excluded from the organ transplantation rate. This change applies to outcome measure reporting beginning with the 2027 assessment period and CMS will recalculate 2026 median and top-25% thr…
- New Rules for OPO Designation and Competition: mixed, medium. The rule revises OPO designation, re-certification, and competition policies, clarifies when a Donation Service Area (DSA) is open to competition, and updates appeals and actions affecting OPO agreements (including non-renewal and de-certification). CMS will evaluate each DSA separately for outcome…
- Estimated Implementation Costs and Benefits: cost, medium. CMS estimates the final rule will cost about $16.5 million in the first year and $7.9 million annually thereafter, and produce roughly $598,000 in annual benefits from reduced inquiries and compliance-interpretation burden. These figures are described as incremental to the December 2020 OPO rule fr…
- New Operational and Recordkeeping Requirements: cost, medium. The final rule adds or clarifies operational requirements: clarified staff licensure requirements, expanded information management to include records for organs procured for research, and new Quality Assessment and Performance Improvement (QAPI) requirements related to medically complex donors and…

## Related documents

- [2026-22194](https://policyrisk.com/federal-register/2026-22194): Medicare Program; CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury (AKI) Dialysis Paym…, 2026-10-30
- [2026-21420](https://policyrisk.com/federal-register/2026-21420): Medicare Program; Implementation of Sections 6219, 6220, and 6224 of the Consolidated Appropriations Act, 2026, 2026-10-20
- [2026-20281](https://policyrisk.com/federal-register/2026-20281): Global Benchmark for Efficient Drug Pricing (GLOBE) Model, 2026-10-02
- [2026-20131](https://policyrisk.com/federal-register/2026-20131): Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2027 and Updates to the IRF Quality…, 2026-10-01
- [2026-19959](https://policyrisk.com/federal-register/2026-19959): Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities; Updates to the Quality Reporting Prog…, 2026-09-30
- [2026-20067](https://policyrisk.com/federal-register/2026-20067): Medicare Program; FY 2027 Hospice Wage Index and Payment Rate Update and Hospice Quality Reporting Program Requirements; Correction, 2026-09-30

## Sources
- [2026-22381 on federalregister.gov](https://www.federalregister.gov/documents/2026/11/03/2026-22381/medicare-and-medicaid-programs-organ-procurement-organizations-conditions-for-coverage-revisions-to)
- [2026-22381 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-11-03/pdf/2026-22381.pdf)

## Related
- [Previous: 2026-22380, Nondiscrimination on the Basis of Disability in Programs or Activities Receivin…](https://policyrisk.com/federal-register/2026-22380)
- [Next: 2026-22402, Compliance Procedure (52 U.S.C. 30109, 30107(a))](https://policyrisk.com/federal-register/2026-22402)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-22381 (as of 2026-11-10).
